Last reviewed · How we verify
Arm 1 Oral Cortico Steroids
Arm 1 Oral Cortico Steroids is a Corticosteroid Small molecule drug developed by University of British Columbia. It is currently FDA-approved for Inflammatory and autoimmune conditions (specific indication not detailed in study arm description), Immunosuppression in clinical research settings. Also known as: Prednisone.
Oral corticosteroids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression.
Oral corticosteroids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression. Used for Inflammatory and autoimmune conditions (specific indication not detailed in study arm description), Immunosuppression in clinical research settings.
At a glance
| Generic name | Arm 1 Oral Cortico Steroids |
|---|---|
| Also known as | Prednisone |
| Sponsor | University of British Columbia |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Immunology, Rheumatology, Endocrinology |
| Phase | FDA-approved |
Mechanism of action
Corticosteroids enter cells and bind to cytoplasmic glucocorticoid receptors, which then translocate to the nucleus and alter transcription of pro-inflammatory genes. This results in decreased production of cytokines, chemokines, and adhesion molecules, leading to broad immunosuppression and anti-inflammatory effects across multiple tissues.
Approved indications
- Inflammatory and autoimmune conditions (specific indication not detailed in study arm description)
- Immunosuppression in clinical research settings
Common side effects
- Hyperglycemia
- Hypertension
- Osteoporosis
- Infection (increased susceptibility)
- Insomnia
- Mood changes
- Weight gain
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Arm 1 Oral Cortico Steroids CI brief — competitive landscape report
- Arm 1 Oral Cortico Steroids updates RSS · CI watch RSS
- University of British Columbia portfolio CI
Frequently asked questions about Arm 1 Oral Cortico Steroids
What is Arm 1 Oral Cortico Steroids?
How does Arm 1 Oral Cortico Steroids work?
What is Arm 1 Oral Cortico Steroids used for?
Who makes Arm 1 Oral Cortico Steroids?
Is Arm 1 Oral Cortico Steroids also known as anything else?
What drug class is Arm 1 Oral Cortico Steroids in?
What development phase is Arm 1 Oral Cortico Steroids in?
What are the side effects of Arm 1 Oral Cortico Steroids?
What does Arm 1 Oral Cortico Steroids target?
Related
- Drug class: All Corticosteroid drugs
- Target: All drugs targeting Glucocorticoid receptor
- Manufacturer: University of British Columbia — full pipeline
- Therapeutic area: All drugs in Immunology, Rheumatology, Endocrinology
- Indication: Drugs for Inflammatory and autoimmune conditions (specific indication not detailed in study arm description)
- Indication: Drugs for Immunosuppression in clinical research settings
- Also known as: Prednisone
- Compare: Arm 1 Oral Cortico Steroids vs similar drugs
- Pricing: Arm 1 Oral Cortico Steroids cost, discount & access